title: Variation in ICOSLG influences Crohn's disease susceptibility.
authors.forename: Paul
authors.initials: P
authors.lastname: Henderson
authors.forename: Johan
authors.initials: J
authors.lastname: van Limbergen
authors.forename: Niall H
authors.initials: NH
authors.lastname: Anderson
authors.forename: Elaine R
authors.initials: ER
authors.lastname: Nimmo
authors.forename: Richard K
authors.initials: RK
authors.lastname: Russell
authors.forename: Jack
authors.initials: J
authors.lastname: Satsangi
authors.forename: David C
authors.initials: DC
authors.lastname: Wilson
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology*; D003092:Colitis / Q000188:drug therapy*; D016753:Interleukin-10 / Q000378:metabolism*; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D016753:Interleukin-10